Nxu announced it is progressing towards closing its merger with Verde Bioresins. On February 11, 2025, approximately 99% of the votes cast by Nxu‘s shareholders approved the issuance of shares of Nxu common stock in connection with and change of control resulting from the contemplated merger, and both Nxu and Verde have been through remaining closing items. Completion of the merger is subject to satisfaction of conditions, including Nasdaq approval. “We have been working through the necessary technicalities closely with both Verde and Nasdaq’s listing department, and we intend to close very soon,” said Mark Hanchett, Chairman and CEO at Nxu. “Completing the recent reverse stock split was a key open item required to position the combined company for success upon close.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NXU:
